Maximize your thought leadership

Infracore SA Reports Strong 2025 Financial Results and Proposes Board Expansion

By Advos

TL;DR

Infracore's strong 2025 results, including a 98.7% occupancy rate and a proposed 95% dividend payout, offer investors a stable and high-yield opportunity in Swiss healthcare real estate.

Infracore SA reported CHF 82.5 million in 2025 revenue with a 93.0% EBITDA margin, a 44.5% Net LTV, and will propose electing Dr. Stephan Thaler and Celine Amaudruz to its Board at the March 25 AGM.

By expanding hospital real estate partnerships, Infracore helps modernize healthcare infrastructure, improving patient access to quality medical facilities across Switzerland for a healthier future.

Infracore's portfolio, valued at CHF 1.41 billion using discounted cash flow methods, demonstrates how specialized real estate can thrive with nearly full occupancy in essential sectors.

Found this article helpful?

Share it with your network and spread the knowledge!

Infracore SA Reports Strong 2025 Financial Results and Proposes Board Expansion

Infracore SA, a leading Swiss healthcare real estate company, published its audited consolidated results for the 2025 financial year and outlined proposals for its upcoming Annual General Meeting scheduled for March 25, 2026. The company reported strong financial metrics including CHF 66.1 million in rental income and total revenue including revaluation gains of CHF 82.5 million. The Group recorded EBITDA of CHF 76.7 million, representing a 93.0% margin of total revenue including revaluation, while profit for the period reached CHF 55.8 million.

The company's investment property portfolio, valued using the discounted cash flow method by independent appraiser Wüest Partner AG, stood at CHF 1.412 billion at year-end. Infracore's portfolio maintained exceptional occupancy levels with a 98.7% rate in 2025, translating to a minimal vacancy rate of approximately 1.3%. The company demonstrated significant cash-generation capacity with cash flow from operating activities before changes in working capital amounting to CHF 42.2 million, representing 51.2% of total revenue including revaluation.

Financially, Infracore reported shareholders' equity of CHF 688.7 million and net debt of CHF 627.8 million, resulting in a conservative Net Loan-to-Value ratio of 44.5% relative to the property portfolio's market value. Based on these results, the Board of Directors will propose a dividend corresponding to a 95% payout ratio of profit excluding revaluation results at the AGM. The consolidated financial statements were prepared in accordance with Swiss GAAP FER and authorized for issue on February 18, 2026, with the statutory auditor confirming they present a true and fair view.

Infracore announced plans to strengthen its Board's independent representation by proposing two new independent candidates for election. Dr. Stephan Thaler and Céline Amaudruz will be proposed for election at the AGM, which would result in three independent members on the five-member board alongside Chairman Martin Gafner. This move toward majority independent board membership aligns with best practice corporate governance standards. The company sees growing demand for efficient capital allocation and modern infrastructure solutions among healthcare institutions and positions itself to expand sale-and-leaseback activities through long-term partnerships with hospitals.

For more information about Infracore SA, visit https://www.infracore.ch. Details about Medical Properties Trust, Inc., one of Infracore's controlling shareholders, can be found at https://www.medicalpropertiestrust.com. Information about AEVIS VICTORIA SA, the other controlling shareholder, is available at https://www.aevis.com. The original release can be viewed on https://www.newmediawire.com.

Curated from NewMediaWire

blockchain registration record for this content
Advos

Advos

@advos